Funding for this research was provided by:
regional Junior Researcher Grant from the Sint Maartenskliniek, Nijmegen and the Radboud University Medical Centre, Nijmegen, the Netherlands. (NA)
Received: 28 January 2021
Accepted: 21 May 2021
First Online: 14 June 2021
: Not required.
: Not applicable.
: MM: non-financial support from UCB, outside the submitted work; TvH: personal fees from Eli Lily, non-financial support from UCB, outside the submitted work; EdJ: research grants for the independent research fund of the department of dermatology of the Radboud University Medical Centre Nijmegen, the Netherlands from AbbVie, Pfizer, Novartis, Janssen Pharmaceutica, and Leo Pharma. Has acted as consultant and/or paid speaker for and/or participated in research sponsored by companies that manufacture drugs used for the treatment of psoriasis including AbbVie, Janssen Pharmaceutica, Novartis, Lily, Celgene, Leo Pharma, UCB, and Almirall. The other authors have nothing to disclose.